Mirum Pharmaceuticals, Inc. MIRM Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported short- and long-term operating lease liabilities of -$583K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities decreased by 42.9% year-over-year, from -$408K to -$583K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s short- and long-term operating lease liabilities has grown at a 30.7% compound annual growth rate (CAGR), from -$649K to -$1.9M.